<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Indications for full histopathologic examination of the placenta</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Indications for full histopathologic examination of the placenta</h1>
<div class="graphic"><div class="figure"><div class="ttl">Indications for full histopathologic examination of the placenta</div><div class="cntnt"><table cellspacing="0"><colgroup width="20%"></colgroup> <colgroup span="2" width="40%"></colgroup> <tbody> <tr> <td class="subtitle1"> </td> <td class="subtitle1">Recommended criteria based on the expert opinion of 16 placental pathologists and a pathologists' assistant, formulated using a modified Delphi approach<sup>[1]</sup></td> <td class="subtitle1">Other suggested criteria*</td> </tr> <tr> <td class="subtitle2_left" colspan="3">Antepartum indications</td> </tr> <tr> <td class="indent1">Maternal indications</td> <td> <ul> <li>Maternal death</li> <li>Systemic disease/disorders exclusive to: <ul> <li>Diabetes, pregestational or poorly controlled gestational</li> <li>Infection potentially associated with fetal infection (eg, cytomegalovirus, syphilis, Zika virus, COVID-19)</li> <li>Metastatic cancer</li> <li>Severe hypertensive disorder (eg, chronic hypertension, gestational hypertension, preeclampsia with severe features, eclampsia, HELLP syndrome)</li> <li>Systemic autoimmune disease (eg, antiphospholipid antibody syndrome)</li> </ul> </li> </ul> </td> <td> <ul> <li>Alcohol use disorder, tobacco smoking, and substance use disorder (including use of medication for opioid use disorder [eg, methadone])</li> <li>Assisted reproductive therapies including gestational carrier pregnancies, gamete donor pregnancies, and in vitro fertilization</li> <li>Body mass index ≥40 kg/m<sup>2</sup></li> <li>IUD in place</li> <li>Prior uterine surgery involving breach of the endometrium (eg, submucosal myomectomy, endometrial ablation) other than cesarean birth</li> <li>Systemic disease/disorders, including any of the following: <ul> <li>Anemia requiring transfusions or with symptoms</li> <li>Cancer, any</li> <li>Cardiovascular compromise (any)</li> <li>Diabetes, any</li> <li>Hemoglobinopathy (eg, sickle cell disease or trait)</li> <li>Hypertension, any</li> <li>Thrombophilia</li> </ul> </li> <li>Younger or older age (eg, &lt;16 or &gt;40 years)</li> </ul> </td> </tr> <tr> <td class="indent1">Obstetric indications</td> <td> <ul> <li>History of a previous placental pathology known to recur (eg, abruption, chronic histiocytic intervillositis, massive perivillous fibrin deposition/maternal floor infarct, villitis of unknown etiology)</li> <li>Pregnancy loss</li> <li>Second- or third-trimester antenatal bleeding</li> </ul> </td> <td> <ul> <li>Cervical insufficiency treated with cerclage</li> <li>Multiple gestation, any</li> <li>No prenatal care</li> <li>Oligohydramnios</li> <li>Postdates delivery (&gt;42 0/7 weeks)</li> <li>Prolonged rupture of membranes (&gt;24 hours)</li> <li>Vanishing twin</li> </ul> </td> </tr> <tr> <td class="indent1">Fetal indications</td> <td> <ul> <li>Complications associated with multiple gestation (eg, twin-to-twin transfusion, selective growth restriction, twin anemia-polycythemia sequence, twin reversed arterial perfusion sequence, single fetal demise, conjoined twins)</li> <li>Fetal demise</li> <li>Fetal growth restriction</li> <li>Hydrops fetalis</li> <li>Severe fetal anomaly (eg, sirenomelia, congenital heart disease, renal agenesis, congenital pulmonary airway malformation, encephalocele, omphalocele, gastroschisis)</li> </ul> </td> <td> <ul> <li>Abnormal genetic test results</li> <li>Anomalies, major; especially deformations and disruptions</li> </ul> </td> </tr> <tr> <td class="subtitle2_left" colspan="3">Intrapartum indications</td> </tr> <tr> <td class="indent1"> </td> <td> <ul> <li>Acute abruption</li> <li>Thick meconium in amniotic fluid</li> <li>Nonreassuring fetal heart rate tracing requiring urgent or emergency delivery</li> <li>Postpartum hemorrhage</li> <li>Preterm delivery (&lt;37 weeks)</li> <li>Suspected chorioamnionitis</li> </ul> </td> <td> <ul> <li>Extramural birth (eg, birth at home)</li> <li>Meconium-stained amniotic fluid, any</li> <li>Nonreassuring fetal heart rate tracing (eg, NICHD category II or III)</li> <li>Peripartum hysterectomy</li> <li>Precipitous birth</li> <li>Shoulder dystocia</li> <li>Umbilical cord prolapse</li> <li>Uterine rupture</li> </ul> </td> </tr> <tr> <td class="subtitle2_left" colspan="3">Neonatal indications</td> </tr> <tr> <td class="indent1"> </td> <td> <ul> <li>Anatomic anomaly, not detected prenatally</li> <li>Compromised clinical condition of the neonate at birth defined as any of the following: <ul> <li>Apgar score of &lt;7 at 5 minutes</li> <li>Cord blood pH &lt;7</li> <li>Need for ventilatory assistance</li> <li>Neurological compromise (suspected hypoxic-ischemic encephalopathy)</li> <li>Persistent hypoglycemia (eg, requiring intravenous dextrose)</li> <li>Resuscitation &gt;10 minutes</li> <li>Severe anemia (eg, hemoglobin &lt;10 or 11 g/dL)</li> </ul> </li> <li>Neonatal death</li> <li>Suspected malignancy</li> <li>Suspected meconium aspiration</li> <li>Suspected sepsis</li> </ul> </td> <td> <ul> <li>Small or large for gestational age</li> </ul> </td> </tr> <tr> <td class="subtitle2_left" colspan="3">Placental indications</td> </tr> <tr> <td class="indent1"> </td> <td> <ul> <li>Retained placenta (to rule out placental accreta spectrum)</li> <li>Severe placental anomaly (eg, mass, massive fibrin deposition, discolored membranes, placenta membranacea)</li> </ul> </td> <td> <ul> <li>Placental disorders (eg, placenta accreta spectrum, placenta previa, vasa previa)</li> <li>Unusual findings in any aspect of the placenta gross examination by an experienced examiner</li> </ul> </td> </tr> <tr> <td class="subtitle2_left" colspan="3">Other</td> </tr> <tr> <td class="indent1"> </td> <td> <ul> <li>Pregnancy termination for obstetric or maternal indications</li> </ul> </td> <td> <ul> <li>Pregnancy termination for fetal indications</li> </ul> </td> </tr> </tbody></table></div><div class="graphic_footnotes"><p>NICHD: National Institute of Child Health and Human Development; IUD: intrauterine device; HELLP: hemolysis, elevated liver enzymes, low platelets.</p>
* Additional suggested criteria provided by Drucilla J Roberts, MD, a co-author on the referenced publication below.</div><div class="graphic_reference">Adapted from:
<ol>
<li>Roberts DJ, Baergen RN, Boyd TK, et al. Criteria for placental examination for obstetrical and neonatal providers. Am J Obstet Gynecol 2022.</li>
</ol></div><div id="graphicVersion">Graphic 141228 Version 2.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
